Shanghai GenTech Co., Ltd. (SHA:688596)
China · Delayed Price · Currency is CNY 31.88
-0.03 (-0.09%)
At close: Mar 6, 2026
Shanghai GenTech Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Revenue | 4,920 | 5,468 | 3,835 | 2,705 | 1,836 |
Other Revenue | - | 0.96 | 0.17 | 0.21 | 0.43 |
| 4,920 | 5,469 | 3,835 | 2,705 | 1,837 | |
Revenue Growth (YoY) | -10.04% | 42.63% | 41.78% | 47.26% | 65.63% |
Cost of Revenue | - | 4,065 | 2,810 | 1,972 | 1,363 |
Gross Profit | 4,920 | 1,404 | 1,024 | 732.46 | 473.72 |
Selling, General & Admin | - | 398.79 | 338.34 | 311.36 | 219.8 |
Research & Development | - | 349.28 | 251.02 | 149.91 | 78.22 |
Other Operating Expenses | 4,817 | -3.48 | -11.02 | 11.19 | 11.02 |
Operating Expenses | 4,817 | 825.96 | 644.13 | 504.73 | 327.36 |
Operating Income | 103.3 | 578.23 | 380.15 | 227.73 | 146.36 |
Interest Expense | - | -31.51 | -25.93 | -18.25 | -3.68 |
Interest & Investment Income | - | 10.46 | 22.92 | 14.07 | 10.18 |
Currency Exchange Gain (Loss) | - | -2.1 | -4.77 | -0.66 | -0.24 |
Other Non Operating Income (Expenses) | 5.08 | -0.5 | -4.08 | -2.77 | -1.71 |
EBT Excluding Unusual Items | 108.38 | 554.58 | 368.29 | 220.12 | 150.92 |
Gain (Loss) on Sale of Investments | - | -24.44 | 53.68 | 25.7 | 16.29 |
Gain (Loss) on Sale of Assets | - | -4.44 | 0.01 | -0.01 | 0.11 |
Other Unusual Items | - | 63.93 | 18.55 | 22.19 | 16.02 |
Pretax Income | 108.38 | 589.62 | 440.53 | 268 | 183.34 |
Income Tax Expense | -29.61 | 20.8 | 17.14 | 6.73 | 15.21 |
Earnings From Continuing Operations | 137.98 | 568.82 | 423.39 | 261.27 | 168.13 |
Minority Interest in Earnings | - | -41.08 | -22.05 | -2.51 | 0.27 |
Net Income | 137.98 | 527.75 | 401.34 | 258.77 | 168.4 |
Net Income to Common | 137.98 | 527.75 | 401.34 | 258.77 | 168.4 |
Net Income Growth | -73.85% | 31.50% | 55.10% | 53.66% | 35.53% |
Shares Outstanding (Basic) | 287 | 281 | 273 | 256 | 255 |
Shares Outstanding (Diluted) | 287 | 284 | 281 | 264 | 259 |
Shares Change (YoY) | 1.31% | 1.10% | 6.29% | 1.92% | 20.93% |
EPS (Basic) | 0.48 | 1.88 | 1.47 | 1.01 | 0.66 |
EPS (Diluted) | 0.48 | 1.86 | 1.43 | 0.98 | 0.65 |
EPS Growth | -74.19% | 30.07% | 45.92% | 50.77% | 12.07% |
Free Cash Flow | - | -25.23 | -244.64 | -421.95 | -206.8 |
Free Cash Flow Per Share | - | -0.09 | -0.87 | -1.60 | -0.80 |
Dividend Per Share | - | 0.280 | 0.286 | - | 0.134 |
Dividend Growth | - | -2.41% | - | - | 34.28% |
Gross Margin | 100.00% | 25.67% | 26.71% | 27.08% | 25.79% |
Operating Margin | 2.10% | 10.57% | 9.91% | 8.42% | 7.97% |
Profit Margin | 2.80% | 9.65% | 10.47% | 9.57% | 9.17% |
Free Cash Flow Margin | - | -0.46% | -6.38% | -15.60% | -11.26% |
EBITDA | 188.79 | 663.71 | 440.38 | 270.4 | 181.03 |
EBITDA Margin | 3.84% | 12.13% | 11.48% | 10.00% | 9.86% |
D&A For EBITDA | 85.49 | 85.49 | 60.23 | 42.67 | 34.66 |
EBIT | 103.3 | 578.23 | 380.15 | 227.73 | 146.36 |
EBIT Margin | 2.10% | 10.57% | 9.91% | 8.42% | 7.97% |
Effective Tax Rate | - | 3.53% | 3.89% | 2.51% | 8.30% |
Revenue as Reported | - | 5,469 | 3,835 | 2,705 | 1,837 |
Advertising Expenses | - | 6.31 | 3.11 | 0.53 | 2.11 |
Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.